NCT04609566 2026-03-16Brentuximab Vedotin With Pembrolizumab in Metastatic Solid TumorsSeagen Inc.Phase 2 Completed161 enrolled
NCT01712490 2026-02-27A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin LymphomaTakedaPhase 3 Completed1,334 enrolled 23 charts